<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Locher R</dc:creator>
  <dc:creator>Weisser B</dc:creator>
  <dc:creator>Mengden T</dc:creator>
  <dc:creator>Brunner C</dc:creator>
  <dc:creator>Vetter W</dc:creator>
  <dc:date>1992</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Oxidation of low density lipoprotein increases its atherogenic potential. During oxidation there is an extensive conversion of lecithin to lysolecithin. In rat aortic smooth muscle cells, 2-25 micrograms/ml lysolecithin elevated cytosolic calcium concentration up to 560%. Lysolecithin (10-20 micrograms/ml) increased [3H]thymidine incorporation from 15 cpm/mg cell protein (controls) up to 189 cpm/mg cell protein. Lysolecithin (10 micrograms/ml) potentiated the PDGF-induced (50 ng/ml) [3H]thymidine incorporation up to 6.3 times. The results indicate that lysolecithin could induce mechanisms, by which oxidized low density lipoproteins could promote cell growth and thus contribute to atherosclerosis.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/286854</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/0006-291x(92)91622-w</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/1543486</dc:relation>
  <dc:source>Biochemical and biophysical research communications. - 1992</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Aorta</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Calcium</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Cell Division</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Cells, Cultured</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Cytosol</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Dose-Response Relationship, Drug</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Lysophosphatidylcholines</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Muscle, Smooth, Vascular</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Platelet-Derived Growth Factor</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Rats</dc:subject>
  <dc:title xmlns:ns13="xml" ns13:lang="en">Lysolecithin actions on vascular smooth muscle cells.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
